ABOPM Seal
Donate Today Log In
American Board of Precision Medicine Blogs
The Future of Medicine Starts Here
Stay ahead with expert perspectives on precision medicine, clinical innovation, and the technologies transforming healthcare.

Minimal Residual Disease (MRD): Detecting Cancer at the Molecular Level

by: ABOPM TeamPublished on: 05/03/2026

As a cornerstone of precision oncology, MRD monitoring is shaping the future of cancer care through more accurate, data-driven decision-making.

Precision Oncology
Minimal Residual Disease (MRD): Detecting Cancer at the Molecular Level

A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.

FOLLOW US

LEARN ABOUT THE

ABOPM

CUSTOMER CARE

LEGAL

Copyright 2026. American Board of Precision Medicine. All Rights Reserved.